Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Non-Current Assets: 2020-2022

Historic Other Non-Current Assets for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $300,000.

  • Candel Therapeutics' Other Non-Current Assets rose 12.78% to $300,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $300,000, marking a year-over-year increase of 12.78%. This contributed to the annual value of $300,000 for FY2022, which is 29.25% down from last year.
  • Latest data reveals that Candel Therapeutics reported Other Non-Current Assets of $300,000 as of FY2022, which was down 29.25% from $424,000 recorded in FY2021.
  • Over the past 5 years, Candel Therapeutics' Other Non-Current Assets peaked at $424,000 during FY2021, and registered a low of $300,000 during FY2022.
  • Over the past 3 years, Candel Therapeutics' median Other Non-Current Assets value was $349,000 (recorded in 2020), while the average stood at $357,667.
  • Per our database at Business Quant, Candel Therapeutics' Other Non-Current Assets increased by 21.49% in 2021 and then fell by 29.25% in 2022.
  • Over the past 3 years, Candel Therapeutics' Other Non-Current Assets (Yearly) stood at $349,000 in 2020, then increased by 21.49% to $424,000 in 2021, then decreased by 29.25% to $300,000 in 2022.